HuScan® PhIP-Seq Antibody Profiling Service

High-throughput Human Autoantibody Profiling

Human proteome epitope-level autoantibody profiling services via T7 phage immunoprecipitation sequencing (PhIP Seq)

REQUEST INFO

Epitope-level Antibody Discovery Against the Entire Human Proteome

HuScan® service allows the analysis of patient samples (serum, plasma, CSF, etc.) for the presence of autoantibodies against a full RefSeq human proteome in a single-well assay with quantitative sequencing readouts. HuScan is available as a service to both academic and industry customers.

HuScan PhIP-Seq Library Curation and Production

HuScan enables simultaneous epitope-level autoantibody profiling against an entire human proteome via phage immunoprecipitation sequencing (PhIP-Seq).

PhIP-Seq Library Curation and Production Figure

HuScan PhIP-Seq Methods and Analysis

HuScan enables simultaneous epitope-level autoantibody profiling against an entire human proteome.

PhIP-Seq Methods and Analysis Figure


HuScan® PhIP-Seq Advantages

Empowering researchers to decode the antibodies shaped by an individual’s unique history of immune exposures

Ultimate Coverage

Detect antibodies targeting virtually any antigen using overlapping long peptides

Total Proteome Profiling

Dive deep into epitope-level insights across the entire RefSeq human proteome

Innovative Technology

Powered by state-of-the-art Phage ImmunoPrecipitation Sequencing for unmatched precision

Transformative Results

Advance autoimmune research, identify biomarkers, and map immune exposure histories

Unparalleled Coverage

Contains over 48,000+ proteins and isoforms, covering over 730,000+ unique peptide sequences

HuScan® Service at CDI Labs

Technical Details

The HuScan human proteome PhIP-Seq library contains all annotated human protein sequences from an NCBI RefSeq database, including all published and computationally predicted splice variants and coding regions. The dataset was obtained in November 2015; after removing duplicates and partial entries through clustering at 99% sequence identity. Each protein was further divided into 49-amino acid peptides through a 25-AA sliding window approach. To eliminate redundant sequences from identical regions of the different isoforms and homologs, the 49-AA peptides were clustered and combined at 95% identity, where peptides with two or fewer differences in amino acids were represented by a single, representative sequence. The final library contains 731,724 unique peptide sequences that represent a full human proteome of 48,921 proteins and protein isoforms.

This was ordered as an oligonucleotide library, PCR-amplified with adaptors for cloning, and packaged into a T7 phage display vector that was expanded in E. Coli. An aliquot from this library is then reacted with diluted patient serum or other antibody-containing fluid. Bound antibodies are immunoprecipitated with protein A/G beads, the precipitate amplified by PCR, and the sequences quantified by a next-generation sequencing and analysis pipeline that compares patient-sample IP read counts to negative controls with no antibody input (mock IPs) in the context of overall clonal frequency of individual peptides in the parent library. Output data are then created at both the peptide level. A more detailed description of this process is available (Mohan, et. al., 2018).

Service Details and Data Deliverables

A HuScan service involves case and control serum or plasma samples. These undergo a protein A/G pulldown assay, PCR amplification, and next-generation sequencing. Raw sequence data are run through a normalization and quantitation pipeline as previously described. Raw pipeline counts outputs are then provided to customers alongside normalized hit calls data for all individual 49mer peptides.

Sample Requirements

Serum or plasma20 μL aliquot per sample
Cerebrospinal fluid (CSF)250 μL aliquot per sample
Other antibodies (IgG monoclonals, B cell supernatants, etc)250 μL aliquot per sample at 0.01 mg/mL concentration
12 sample minimumSold in multiples of x12 samples (i.e., x12, x24, x36, x48 – full rows of a standard 96-well plate), and any number after 48 samples
Cohort balancing (studies bigger > 336 samples)

Individual PhIP-Seq studies are prepared in x96 well plates using aliquots of our phage library; each study requires x48 controls pooled plasma, known polyclonal, and protein A/G beads-only internal control samples per sequencer run (provided free-of-charge). Data are most reproducible within a single sequencer run. Sequencer runs are currently limited to 4x 96-well plates (336 experimental samples + x48 controls per run).

Sample Shipping and Sample Return

We will include shipping details in your quote – you must cover the cost of shipping samples to CDI Labs. Typically, after you receive your report, CDI Labs keeps the remaining samples for two months and then disposes of them. When shipping to us, please let us know if you want the remaining samples returned after the study is complete. Return shipping will be charged.

Ready to Transform Your Research?

Discover how HuScan PhIP-Seq can revolutionize your understanding of human immune responses
and accelerate your research breakthroughs.

REQUEST INFO / QUOTE

What Our Customers Are Saying

"With CDI Labs, identifying antibodies and their targets has never been so simple. Their passionate team, robust science and high-quality service unlock the discovery of new mechanisms, biomarkers and therapeutic targets."

Matthieu Roulleaux DugageGustave Roussy View poster, "Baseline serum level of IgG targeting annexin A2 is predictive of response to immunotherapy in patients with advanced NSCLC" presented at IMMUNOLOGY 2025

What Our Customers Are Saying

"We enjoyed working with CDI Labs. We used both VirScan and HuScan services from CDI Labs as part of our neurodegenerative disease research. The team at CDI Labs was very responsive and great to work with, and they went above and beyond to get us our results very quickly. They were particularly helpful in making contract arrangements and ensuring that everything was in place for a smooth collaboration. CDI Labs also provided a comprehensive statistical analysis, which will be invaluable as we build on our research. We’re still analyzing the data, but we’re confident that we’ll gain new insights into disease mechanisms that will advance our research."

Wouter Peelaerts, PhDProfessor, KU Leuven

What Our Customers Are Saying

"CDI Labs provide consistent service and consistently high-quality protein array products to our lab. Their sales and scientific team are courteous and timely in their responses to our queries.”

Dr. Andrew McKeonMayo Clinic College of Medicine & Science

Data and Technology Validated by Scientists

"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."

OncologistSchool of Medicine Research (as mentioned in "Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade" - AACR Clinical Caner Research - September 2022)

Data and Technology Validated by Scientists

"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."

Faculty of MedicineResearch Institution (as mentioned in "Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC" - Science Advances - November 2023)

Data and Technology Validated by Scientists

"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."

Senior ScientistBiotech Research (poster presentation at the San Antonio Breast Cancer Symposium 2023)